Detailed Information

Cited 5 time in webofscience Cited 5 time in scopus
Metadata Downloads

Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis

Full metadata record
DC Field Value Language
dc.contributor.authorAhn, Sang Bong-
dc.contributor.authorJun, Dae Won-
dc.contributor.authorKim, Sang Gyune-
dc.contributor.authorLee, Sae Hwan-
dc.contributor.authorShin, Hyun Phil-
dc.contributor.authorChoe, Won Hyeok-
dc.contributor.authorKim, Ja Kyung-
dc.contributor.authorJung, Kyu Sik-
dc.contributor.authorKim, Do Young-
dc.contributor.authorShim, Jae-Jun-
dc.contributor.authorPark, Soo Young-
dc.contributor.authorSeo, Yeon Seok-
dc.contributor.authorKim, Won-
dc.contributor.authorChung, Jae Il-
dc.date.available2020-11-02T15:44:08Z-
dc.date.issued2015-05-
dc.identifier.issn0953-6205-
dc.identifier.issn1879-0828-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/7963-
dc.description.abstractIntroduction: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) on dialysis are difficult to treat and show higher dropout rates during treatment. The aim of this study was to analyze the treatment outcomes in patients with CHC and underlying end-stage renal disease on dialysis in Korea. Methods: A retrospective multi-center study of 35 patients with CHC and underlying ESRD on regular dialysis from 13 centers were analyzed. We investigated the tolerability and efficacy of pegylated interferon therapy with or without ribavirin on dialysis patients. Results: Twenty patients (57%) were genotype 1. Sixteen patients (46%) were treated with pegylated interferon monotherapy. Nineteen patients (54%) were treated with pegylated interferon and ribavirin. The overall sustained virological response (SVR) rate was 65.7% in all subjects. Thirteen patients (37%) dropped out before completion of treatment, and six patients (46.2%) showed SVR despite premature termination of treatment. Twenty patients (90.9%) achieved SVR among the 22 patients who completed the scheduled course. The most common side effects were anemia and neutropenia. The patients receiving ribavirin treatment showed a higher dropout rate (52.6% vs. 18.8%, p = 0.04) and higher SVR rate (68.4% vs. 62.5%, p = 0.07) compared to the pegylated interferon mono-treatment group. Conclusions: The difficulty in treating HCV patients with ESRD was attributed to higher dropout rate. However, despite the high dropout rate (37%), the SVR rate in genotype 1 was 65% and in genotypes 2 and 3 was 66%. Patients who completed the treatment showed a high SVR rate of 89.5%. (C) 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.-
dc.format.extent5-
dc.language영어-
dc.language.isoENG-
dc.publisherELSEVIER SCIENCE BV-
dc.titleEfficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis-
dc.typeArticle-
dc.publisher.location네델란드-
dc.identifier.doi10.1016/j.ejim.2015.03.011-
dc.identifier.scopusid2-s2.0-84928826993-
dc.identifier.wosid000353549900021-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF INTERNAL MEDICINE, v.26, no.4, pp 292 - 296-
dc.citation.titleEUROPEAN JOURNAL OF INTERNAL MEDICINE-
dc.citation.volume26-
dc.citation.number4-
dc.citation.startPage292-
dc.citation.endPage296-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.subject.keywordPlusLOW-DOSE RIBAVIRIN-
dc.subject.keywordPlusHEMODIALYSIS-PATIENTS-
dc.subject.keywordPlusVIRUS-INFECTION-
dc.subject.keywordPlusPLUS RIBAVIRIN-
dc.subject.keywordPlusRECEIVING HEMODIALYSIS-
dc.subject.keywordPlusRANDOMIZED-TRIAL-
dc.subject.keywordPlusPEGYLATED-INTERFERON-ALPHA-2A-
dc.subject.keywordPlusPEGINTERFERON-ALPHA-2A-
dc.subject.keywordPlusTOLERABILITY-
dc.subject.keywordPlusMETAANALYSIS-
dc.subject.keywordAuthorHepatitis C-
dc.subject.keywordAuthorPegylated interferon-
dc.subject.keywordAuthorDialysis-
dc.subject.keywordAuthorRenal insufficiency-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Seo, Yeon Seok photo

Seo, Yeon Seok
Anam Hospital (Department of Gastroenterology and Hepatology, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE